KLOW Blend is a research-grade four-peptide blend supplied in a single co-lyophilized vial BPC-157 (10 mg), GHK-Cu (50 mg), TB-500 (10 mg) and KPV (10 mg), 80 mg combined
It has not been evaluated by the FDA for therapeutic purposes, and researchers must follow local regulations for handling and disposal
Die Wahl der richtigen Anwendungsform ist dabei entscheidend fr die Wirksamkeit und sollte stets in Absprache mit einem erfahrenen Mediziner erfolgen
Patients must engage in resistance training, and adopt sufficient protein intake and physical activity to maintain or build muscle preventing frailty or metabolic slow-down
When administered by licensed clinicians under physician supervised protocols, glutathione IV therapy is generally considered safe for appropriate candidates
It is not intended for human consumption, nor for therapeutic, diagnostic, veterinary, or household use